• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

    12/4/24 8:30:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care
    Get the next $ICU alert in real time by email

    DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a conference call to discuss business progress and updates.

    Date/Time:Wednesday, December 11, 4:30 p.m. ET / 1:30 p.m. PT
      
    Pre-Registration: Participants can pre-register for the conference call here:
      
     Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
      
    Dial In:Those who choose not to pre-register can access the live conference call by dialing the following and requesting the SeaStar Medical call:
     866-777-2509 within the U.S.
     412-317-5413 from outside the U.S.
      

    The live webcast of the conference call also will be available here. A replay of the call will be available for 48 hours beginning two hours after its completion by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 3855739. The webcast will also be archived here.

    About SeaStar Medical

    SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical's novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit www.seastarmedical.com or visit us on LinkedIn or X.

    Contact:

    Alliance Advisors IR

    Jody Cain

    (310) 691-7100

    [email protected]

    # # #



    Primary Logo

    Get the next $ICU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • When is the SeaStar Medical conference call scheduled?

      The conference call will take place on December 11, 2024, at 4:30 p.m. ET.

    • How can participants join the conference call?

      Participants can pre-register for the conference call via a provided link to gain immediate access.

    • What are the dial-in numbers for the SeaStar Medical conference call?

      Those in the U.S. can dial 866-777-2509, while international callers can reach 412-317-5413.

    • Will there be a replay available for the conference call, and how can one access it?

      A replay of the call will be available for 48 hours after its completion by dialing specific numbers based on the caller's location.

    • What is the primary focus of SeaStar Medical as a company?

      SeaStar Medical is focused on developing technologies that reduce hyperinflammation effects on vital organs.

    Recent Analyst Ratings for
    $ICU

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ICU
    Financials

    Live finance-specific insights

    See more
    • SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

      DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, May 14, 2025, at 4:30 p.m. ET / 2:30 p.m. MTWebcast:The live webcast and replay can be found here.Conference ID:2078693Dial-in numbers:1 (800) 715-9871 within the U.S. 1 (646) 307-1963 from outside the U.S.   A rep

      5/7/25 10:00:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

      DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and year ended December 31, 2024, and provided business updates on key initiatives. "Our significant accomplishment in 2024 position us well for a transformational year in 2025," said Eric Schlorff, SeaStar Medical CEO. "Last year, we not only received our first product approval for QUELIMMUNE and began our commercial launch, but we added 14 new clinical sites for our NEUTRALIZE AKI pivotal clinic

      3/27/25 4:05:00 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

      DENVER, March 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2024 financial results after market close on Thursday, March 27, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT  Webcast:The live webcast and replay can be found here.  Conference ID:2078693  Dial-in numbers:1 (800) 715-9871 within the U.S.   1 (646) 307-1963 from outside

      3/24/25 5:30:00 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Medical Officer Chung Kevin

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      4/3/25 7:33:39 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Green David A

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      4/3/25 7:33:07 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Director Neuman John bought $153,227 worth of shares (40,000 units at $3.83) (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      2/27/25 3:51:55 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaStar Medical Holding Corporation

      SC 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

      11/14/24 5:35:52 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

      DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has successfully reached the halfway point in the NEUTRALIZE-AKI pivotal clinical trial, enabling a per protocol prespecified interim analysis by the trial's independent Data Safety Monitoring Review Board (DSMB). SeaStar Medical anticipates the DSMB will report its findings to the company in the third quarter of 2025. The NEUTRALIZE-AKI trial is evaluating the SCD therapy as a treatment for adult patients with Acute Kidney In

      5/13/25 8:05:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

      DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, May 14, 2025, at 4:30 p.m. ET / 2:30 p.m. MTWebcast:The live webcast and replay can be found here.Conference ID:2078693Dial-in numbers:1 (800) 715-9871 within the U.S. 1 (646) 307-1963 from outside the U.S.   A rep

      5/7/25 10:00:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

      DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, CEO of SeaStar Medical, will be a featured guest today, Wednesday, April 30th, at approximately 10:50 am Eastern Time on the Benzinga All Access Show. The event will be broadcast live and can be viewed at https://youtube.com/live/ki1hFktn_2Y?feature=share. An archived recording of the presentation will be available on the investor relations section of the Sea Star Medical's website on the Events and Presentations pa

      4/30/25 8:05:00 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    SEC Filings

    See more
    • SEC Form DEF 14A filed by SeaStar Medical Holding Corporation

      DEF 14A - SeaStar Medical Holding Corp (0001831868) (Filer)

      5/7/25 9:05:41 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by SeaStar Medical Holding Corporation

      DEFA14A - SeaStar Medical Holding Corp (0001831868) (Filer)

      5/6/25 5:26:23 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by SeaStar Medical Holding Corporation

      EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)

      4/30/25 12:15:20 AM ET
      $ICU
      Medical/Dental Instruments
      Health Care

    $ICU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Neuman John bought $153,227 worth of shares (40,000 units at $3.83) (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      2/27/25 3:51:55 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Chief Medical Officer Chung Kevin bought $8,458 worth of shares (4,250 units at $1.99), increasing direct ownership by 45% to 13,685 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      11/19/24 5:18:50 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care
    • Chief Medical Officer Chung Kevin bought $4,258 worth of shares (1,000 units at $4.26), increasing direct ownership by 12% to 9,435 units (SEC Form 4)

      4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

      10/1/24 4:47:46 PM ET
      $ICU
      Medical/Dental Instruments
      Health Care